Eli Lilly achieving significant gains in obesity results
The recent rallying of Lilly’s market value has come as the result of two major announcements.
Analysis
ASCO 2023: Keytruda becomes a new option in perioperative NSCLC
Revised EU/Pfizer/BioNTech Covid-19 vaccine deal may lead to a Comirnaty monopoly
AstraZeneca R&D Centre and Corporate Headquarters, Cambridge, UK
Negative FDA AdCom vote for Intercept’s obeticholic acid in NASH
Fusion’s Radiopharmaceutical Manufacturing Facility, Ontario, Canada
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
